Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout.

Autor: Taylor W; W. Taylor, MBChB, PhD, FRACP, FAFRM, University of Otago, Wellington, New Zealand., Dalbeth N; N. Dalbeth, MBChB, MD, FRACP, P. Tan, University of Auckland, Auckland, New Zealand., Saag KG; K.G. Saag, MD, MSc, E.J. Rahn, PhD, A.S. Mudano, MPH, University of Alabama at Birmingham, Birmingham, Alabama, USA., Singh JA; J.A. Singh, MD, MPH, A.L. Gaffo, MD, MSPH, University of Alabama at Birmingham, and Birmingham VA Medical Center, Birmingham, Alabama, USA., Rahn EJ; K.G. Saag, MD, MSc, E.J. Rahn, PhD, A.S. Mudano, MPH, University of Alabama at Birmingham, Birmingham, Alabama, USA., Mudano AS; K.G. Saag, MD, MSc, E.J. Rahn, PhD, A.S. Mudano, MPH, University of Alabama at Birmingham, Birmingham, Alabama, USA., Chen YH; Y.H. Chen, MD, PhD, C.T. Lin, MD, Taichung Veterans General Hospital, Taichung, Taiwan., Lin CT; Y.H. Chen, MD, PhD, C.T. Lin, MD, Taichung Veterans General Hospital, Taichung, Taiwan., Tan P; N. Dalbeth, MBChB, MD, FRACP, P. Tan, University of Auckland, Auckland, New Zealand., Louthreno W; W. Louthreno, MD, Chiang Mai University, Chiang Mai, Thailand., Vazquez-Mellado J; J. Vazquez-Mellado, MD, PhD, H. Hernández-Llinas, MD, Hospital General de Mexico, Mexico City, Mexico., Hernández-Llinas H; J. Vazquez-Mellado, MD, PhD, H. Hernández-Llinas, MD, Hospital General de Mexico, Mexico City, Mexico., Neogi T; T. Neogi, MD, PhD, FRCPC, A.B. Vargas-Santos, MD, Boston University School of Medicine, Boston, Massachusetts, USA., Vargas-Santos AB; T. Neogi, MD, PhD, FRCPC, A.B. Vargas-Santos, MD, Boston University School of Medicine, Boston, Massachusetts, USA., Castelar-Pinheiro G; G. Castelar-Pinheiro, MD, PhD, R.B. Chaves-Amorim, MD, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil., Chaves-Amorim RB; G. Castelar-Pinheiro, MD, PhD, R.B. Chaves-Amorim, MD, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil., Uhlig T; T. Uhlig, MD, H.B. Hammer, MD, PhD, Diakonhjemmet Hospital, Oslo, Norway., Hammer HB; T. Uhlig, MD, H.B. Hammer, MD, PhD, Diakonhjemmet Hospital, Oslo, Norway., Eliseev M; M. Eliseev, PhD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Perez-Ruiz F; F. Perez-Ruiz, MD, PhD, Servicio de Reumatologia, Baracaldo, Spain., Cavagna L; L. Cavagna, MD, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy., McCarthy GM; G.M. McCarthy, MD, FRCPI, Mater Misericordiae University Hospital, Dublin, Ireland., Stamp LK; L.K. Stamp, MBChB, FRACP, PhD, University of Otago-Christchurch, Christchurch, New Zealand., Gerritsen M; M. Gerritsen, MD, PhD, Westfries Gasthuis, Hoorn, the Netherlands., Fana V; V. Fana, MD, Copenhagen Center for Artritis Reserch, Righospitalet Glostrup, Denmark., Sivera F; F. Sivera, MD, PhD, Hospital General Universitario Elda, Elda, Spain., Gaffo AL; J.A. Singh, MD, MPH, A.L. Gaffo, MD, MSPH, University of Alabama at Birmingham, and Birmingham VA Medical Center, Birmingham, Alabama, USA; agaffo@uabmc.edu.

Publikováno v: The Journal of rheumatology [J Rheumatol] 2021 Feb; Vol. 48 (2), pp. 293-298. Date of Electronic Publication: 2020 May 01.